Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities

Multiple myeloma (MM) is the second most common hematologic malignancy, characterized by a multi-step evolutionary path, which starts with an early asymptomatic stage, defined as monoclonal gammopathy of undetermined significance (MGUS) evolving to overt disease in 1% of cases per year, often throug...

Full description

Bibliographic Details
Main Authors: Cirino Botta, Francesco Mendicino, Enrica Antonia Martino, Ernesto Vigna, Domenica Ronchetti, Pierpaolo Correale, Fortunato Morabito, Antonino Neri, Massimo Gentile
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
multiple myeloma
tumor immunology
anti-cancer immune response
immunotherapy
monoclonal antibodies
Online Access:https://www.mdpi.com/2072-6694/13/13/3213

Internet

https://www.mdpi.com/2072-6694/13/13/3213

Similar Items